PRESS RELEASE published on 10/02/2025 at 08:00, 1 year 1 month ago Amoéba accelerates the development of Axpera: Very convincing results observed by winegrowers; An approval schedule in line with the market launch in 2026. Amoéba to present positive results of wine-growing trials with its innovative biological solution 'AXPERA' to agricultural press, amidst changing plant health regulations in France and Europe AMOEBA AXPERA Wine-growing Trials Biological Solution Plant Health Regulations
BRIEF published on 09/08/2025 at 08:05, 1 year 1 month ago Edison sets a price target of EUR 2.01 for Amoéba AMOEBA Course Objective Natural Solutions GreenTech Edison Group
PRESS RELEASE published on 09/08/2025 at 08:00, 1 year 1 month ago Amoéba: Edison sets a target price of EUR 2.01 Amoéba, the greentech company specializing in natural microbiological solutions, receives positive analysis from Edison Group praising future growth potential backed by distribution partnerships and demand for natural products AMOEBA Financial Analysis GreenTech Edison Group Microbiological Solutions
BRIEF published on 07/23/2025 at 08:05, 1 year 3 months ago Successful capital increase for Amoéba AMOEBA Capital Increase New Actions Industrial Support Nice & Green
PRESS RELEASE published on 07/23/2025 at 08:00, 1 year 3 months ago Amoéba announces the success of its capital increase of 14 M EUR to support its industrial and commercial deployment Amoéba (FR0011051598 - ALMIB) successfully raises €14 million through a capital increase to support industrial and commercial expansion. Investors incl. Nice & Green show confidence. New shares to be admitted on Euronext Growth market of Euronext Paris AMOEBA Investors Capital Increase New Shares Euronext Growth
BRIEF published on 07/22/2025 at 18:30, 1 year 3 months ago Amoéba Initiates €9 Million Capital Increase to Bolster Growth AMOEBA Investment Capital Increase Biocontrol Cosmetics
PRESS RELEASE published on 07/22/2025 at 18:25, 1 year 3 months ago Amoéba launches a capital increase open to all to support its industrial and commercial deployment Amoéba, a greentech company, announces a capital increase of up to €14 million to support industrial and commercial growth in biocontrol and cosmetics. Key partners and subscription commitments outlined AMOEBA Capital Increase Biocontrol Cosmetics GreenTech
BRIEF published on 07/22/2025 at 17:50, 1 year 3 months ago Amoéba signs a strategic agreement with Metron Technology in China AMOEBA China Cosmetic Strategic Agreement Oriental Beauty Valley
PRESS RELEASE published on 07/22/2025 at 17:45, 1 year 3 months ago Amoéba signs an agreement with Metron Technology, a subsidiary of Oriental Beauty Valley (OBV), a key player in the cosmetics industry in China Amoéba signs agreement with Metron Technology, subsidiary of Oriental Beauty Valley, for cosmetic ingredient in China. Accelerating entry into second largest cosmetics market AMOEBA China Metron Technology Oriental Beauty Valley Cosmetic Ingredient
BRIEF published on 06/25/2025 at 08:50, 1 year 4 months ago Exemption obtained by Amoéba for its biocontrol product AXP12 AMOEBA Biocontrol Exemption AXP12 ANSES
Published on 11/06/2026 at 22:15, 12 hours 35 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 21 hours 50 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 22 hours 20 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 22 hours 20 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 14 hours 35 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 15 hours 35 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 15 hours 50 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 16 hours 18 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 16 hours 50 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 16 hours 50 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 16 hours 55 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 17 hours 15 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026